Drug
Pamidronate clinical trials
- studies test it
- 28
- open now
- 1
- in phase 3
- 2
- first study started
- 1998
Keep track of what changes. Save the Pamidronate studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
27 studies that test it; most in 2000 (5)
| Year | Studies |
|---|---|
| 1998 | 2 |
| 1999 | 2 |
| 2000 | 5 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 8
- Phase 3
- 2
- Phase 4
- 10
- No phase
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 26
Ottawa Hospital Research Institute (2) · University of Arkansas (2) · Masonic Cancer Center, University of Minnesota (1) · University of New Mexico (1) · Spanish Breast Cancer Research Group (1) · Providence Health & Services (1) · Mayo Clinic (1) · Indiana University School of Medicine (1)
Often tested with
Tested in the same studies.
Zoledronic Acid (3) · Denosumab (2) · Thalidomide (2) · Vitamin D (1) · Alendronate (1) · Golimumab (1) · Arsenic Trioxide (1) · Cyclophosphamide (1)
Studies
Open first, then newest update. How each study uses Pamidronate is read from its arms, and is right about nine times in ten.
Testing it · 28
- Effect of Local Pamidronate in Preventing Bone Loss After Total Hip ArthroplastyNot yet recruitingPhase 1General and Teaching Hospital CeljeNCT00548288Written as pamidronate
- Prevention of Bone Loss After Pediatric Hematopoietic Cell TransplantationCompletedPhase 2Masonic Cancer Center, University of MinnesotaNCT02074631Written as Pamidronate
- Prevention of Post Operative Bone Loss in ChildrenCompletedNot applicableUniversity of New MexicoNCT00655681Written as pamidronate
- Pamidronate Administration in Breast Cancer Patients With Bone MetastasesCompletedPhase 4Spanish Breast Cancer Research GroupNCT00128297Written as Pamidronate
- 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone MetastasesCompletedPhase 4Ottawa Hospital Research InstituteNCT02721433Written as Pamidronate
- Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart TransplantationCompletedNot applicableProvidence Health & ServicesNCT00302627Written as Pamidronate
- Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone PainCompletedPhase 1/2Mayo ClinicNCT00482378Written as Pamidronate
- The Use of Bisphosphonates in the Treatment of Avascular Necrosis of the Femoral HeadTerminatedNot applicableThe Hospital for Sick ChildrenNCT02007915Written as Pamidronate Disodium
- The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast CancerCompletedPhase 4Ottawa Hospital Research InstituteNCT01907880Written as Pamidronate
- Bisphosphonate Therapy for Osteogenesis ImperfectaCompletedPhase 4Indiana University School of MedicineNCT00159419Written as Pamidronate
- Efficacy of Bisphosphonates in Patients With Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) SyndromeCompletedPhase 1Peking Union Medical College HospitalNCT02544659Written as pamidronate disodium
- Pamidronate to Treat Osteogenesis Imperfecta in ChildrenCompletedPhase 3Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NCT00005901Written as Pamidronate (Aredia)
- Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast CancerTerminatedPhase 2HaEmek Medical Center, IsraelNCT01067989Written as Cyclophosphamide, Capecitabine, Methotrexate, Celecoxib, Pamidronate (or Zoledronate)
- Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and ThalidomideCompletedPhase 2University of ArkansasNCT00083382Written as Pamidronate
- Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week TrialCompletedPhase 4Tuen Mun HospitalNCT01718951Written as Pamidronate
- Study of Pamidronate for the Prevention of Heterotopic OssificationWithdrawnNot applicableUniversity Hospital, Basel, SwitzerlandNCT00262392Written as Pamidronate (AREDIA)
- Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone DiseaseWithdrawnPhase 4AmgenNCT02101164Written as pamidronate
- Combined Treatment With TNF Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic ProgressionStatus unknownPhase 4Bnai Zion Medical CenterNCT02313727Written as Pamidronate
- Efficiency and Safety Study of Pamidronate in Inflammatory Back Pain Due to Degenerative Disk DiseaseStatus unknownPhase 2University Hospital, Clermont-FerrandNCT01799616Written as Pamidronate
- Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple MyelomaCompletedPhase 1National Cancer Institute (NCI)NCT00124605Written as pamidronate disodium
See all 28 studies that test Pamidronate →
Given in every arm · 1 — Pamidronate is usual care beside what is tested
Codes
What other systems call Pamidronate · ClinicalTrials.gg INT006681
- MeSH (NLM) D000077268PamidronateConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 8742T8ZQZAPAMIDRONATE DISODIUMConfirmed FDA, NLM, Wikidata
- RxNorm 105443Confirmed FDA, Wikidata
- Wikidata Q27269790pamidronate disodium pentahydrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1345Pamidronate DisodiumOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077268 | Pamidronate | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 8742T8ZQZA | PAMIDRONATE DISODIUM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 105443 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27269790 | pamidronate disodium pentahydrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1345 | Pamidronate Disodium | One source FDA |
Also registered as pamidronate monosodium (UNII MUA93Q6K1J) and pamidronic acid (UNII OYY3447OMC · RxNorm 1546406).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.